CN113336622B - 具有aie特性的芴类衍生物、制备方法及应用 - Google Patents
具有aie特性的芴类衍生物、制备方法及应用 Download PDFInfo
- Publication number
- CN113336622B CN113336622B CN202110381081.4A CN202110381081A CN113336622B CN 113336622 B CN113336622 B CN 113336622B CN 202110381081 A CN202110381081 A CN 202110381081A CN 113336622 B CN113336622 B CN 113336622B
- Authority
- CN
- China
- Prior art keywords
- bottle
- bromofluorene
- dimethyl
- fluorene
- aie
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 8
- 125000003983 fluorenyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 title abstract 2
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 18
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 17
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 34
- 150000001875 compounds Chemical class 0.000 claims description 26
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 22
- 238000001816 cooling Methods 0.000 claims description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 11
- 150000002220 fluorenes Chemical class 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 239000012074 organic phase Substances 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- FXSCJZNMWILAJO-UHFFFAOYSA-N 2-bromo-9h-fluorene Chemical compound C1=CC=C2C3=CC=C(Br)C=C3CC2=C1 FXSCJZNMWILAJO-UHFFFAOYSA-N 0.000 claims description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- MBHPOBSZPYEADG-UHFFFAOYSA-N 2-bromo-9,9-dimethylfluorene Chemical compound C1=C(Br)C=C2C(C)(C)C3=CC=CC=C3C2=C1 MBHPOBSZPYEADG-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 6
- 238000004440 column chromatography Methods 0.000 claims description 6
- 238000007872 degassing Methods 0.000 claims description 6
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000005457 ice water Substances 0.000 claims description 6
- 239000012046 mixed solvent Substances 0.000 claims description 6
- 239000003208 petroleum Substances 0.000 claims description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 4
- 238000002390 rotary evaporation Methods 0.000 claims description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical class [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- DAZFRJAIIUPRQZ-UHFFFAOYSA-N 2-(9,9-dimethylfluoren-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(C=2C(=CC=CC=2)C2(C)C)C2=C1 DAZFRJAIIUPRQZ-UHFFFAOYSA-N 0.000 claims description 3
- BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 claims description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims description 3
- 235000011056 potassium acetate Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- VBXDEEVJTYBRJJ-UHFFFAOYSA-N diboronic acid Chemical compound OBOBO VBXDEEVJTYBRJJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 238000010025 steaming Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 3
- 150000001450 anions Chemical class 0.000 abstract description 2
- 150000001768 cations Chemical class 0.000 abstract description 2
- 239000002360 explosive Substances 0.000 abstract description 2
- 229910052751 metal Inorganic materials 0.000 abstract description 2
- 239000002184 metal Substances 0.000 abstract description 2
- 229910052761 rare earth metal Inorganic materials 0.000 abstract description 2
- 150000002910 rare earth metals Chemical class 0.000 abstract description 2
- 235000001014 amino acid Nutrition 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 238000002189 fluorescence spectrum Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- QAKMXYFDVPDIPT-UHFFFAOYSA-N 1,1,2,3,4,5-hexakis-phenylsilole Chemical compound C1=CC=CC=C1C(C(=C([Si]1(C=2C=CC=CC=2)C=2C=CC=CC=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1C1=CC=CC=C1 QAKMXYFDVPDIPT-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 238000012875 competitive assay Methods 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- KYNMONSTYCGIDJ-VIFPVBQESA-N (2s)-2-amino-3-(1h-indol-2-yl)propanoic acid Chemical compound C1=CC=C2NC(C[C@H](N)C(O)=O)=CC2=C1 KYNMONSTYCGIDJ-VIFPVBQESA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- ZLDMZIXUGCGKMB-UHFFFAOYSA-N 3,5-dibromobenzaldehyde Chemical compound BrC1=CC(Br)=CC(C=O)=C1 ZLDMZIXUGCGKMB-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Natural products C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZOCHARZZJNPSEU-UHFFFAOYSA-N diboron Chemical compound B#B ZOCHARZZJNPSEU-UHFFFAOYSA-N 0.000 description 1
- -1 distyryl anthracene Chemical compound 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000000504 luminescence detection Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 238000007539 photo-oxidation reaction Methods 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- JLZUZNKTTIRERF-UHFFFAOYSA-N tetraphenylethylene Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)=C(C=1C=CC=CC=1)C1=CC=CC=C1 JLZUZNKTTIRERF-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/18—Polycyclic aromatic halogenated hydrocarbons
- C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
- C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
- C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
- C07C13/54—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings
- C07C13/547—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings at least one ring not being six-membered, the other rings being at the most six-membered
- C07C13/567—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings at least one ring not being six-membered, the other rings being at the most six-membered with a fluorene or hydrogenated fluorene ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C22/00—Cyclic compounds containing halogen atoms bound to an acyclic carbon atom
- C07C22/02—Cyclic compounds containing halogen atoms bound to an acyclic carbon atom having unsaturation in the rings
- C07C22/04—Cyclic compounds containing halogen atoms bound to an acyclic carbon atom having unsaturation in the rings containing six-membered aromatic rings
- C07C22/06—Trichloromethylbenzene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C22/00—Cyclic compounds containing halogen atoms bound to an acyclic carbon atom
- C07C22/02—Cyclic compounds containing halogen atoms bound to an acyclic carbon atom having unsaturation in the rings
- C07C22/04—Cyclic compounds containing halogen atoms bound to an acyclic carbon atom having unsaturation in the rings containing six-membered aromatic rings
- C07C22/08—Cyclic compounds containing halogen atoms bound to an acyclic carbon atom having unsaturation in the rings containing six-membered aromatic rings containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/21—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/546—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/33—Polycyclic acids
- C07C63/49—Polycyclic acids containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
技术领域
本发明涉及一种聚集诱导发光(AIE)材料,尤其涉及一种具有AIE特性的芴类衍生物、制备方法及应用。
背景技术
聚集诱导发光(AIE)材料在溶解时表现出微弱的发射甚至非发射,但在聚集或固体状态下表现出强烈的发射。传统的AIE分子大多数以六苯基噻咯(HPS)、四苯乙烯(TPE)或二苯乙烯基蒽(DSA)为母体,但是HPS及其衍生物的合成工艺繁琐,TPE、DSA及其衍生物具有潜在的光漂白和光氧化作用等。荧光探针能够与目标分子或者离子发生特异性结合,促使反应体系的荧光信号在作用后发生改变。目前,已有以聚集诱导发光(AIE)材料为荧光探针的相关报道,但常应用于核酸(DNA或RNA)、蛋白质或其他大分子结构的检测。
氨基酸是蛋白质的组成成分,与生物体的活动息息相关,不同种类的氨基酸在生命体中有着不同的作用。色氨酸(Trp)又称β-吲哚基丙氨酸,是人体的必需氨基酸之一和重要的神经递质-5羟色胺的前体,缺乏色氨酸会使人精神情绪产生不良反应,容易抑郁、激动、失眠以及从梦中惊醒等症状。目前已有多种测定色氨酸的方法,如电化学技术、高效液相色谱(HPLC)、气相色谱(GC)、发光光谱及毛细管电泳(CE)等等。然而,现有方法通常需要专门而昂贵的实验室设备且测量时间长。尽管荧光探针检测具有相对简单、成本低、响应时间短、灵敏度高及专一性强等优势,但是,由于色氨酸为生物小分子,迄今未见使用AIE型荧光探针对其检测的相关报道。
发明内容
本发明是为了解决现有技术所存在的上述技术问题,提供一种具有AIE特性的芴类衍生物、制备方法及应用。
本发明的技术解决方案是:一种具有AIE特性的芴类衍生物,结构式如下:
所述R= -CHO、-COOH、-Br、-I、-NO2、-NH2、-OCH3、-CH3、-CN、-NHCOCH3、-CF3或-CCl3。
一种上述具有AIE特性的芴类衍生物的制备方法,合成路线如下:
依次按照如下步骤进行:
步骤1:先将芴与氯仿加入到瓶中,然后向瓶中加入无水三氯化铁,冰水浴搅拌冷却至0℃后再向瓶中滴加液溴,移去冰水浴继续搅拌2.5~3.5小时,再向反应体系滴加饱和的硫代硫酸钠溶液至红色完全消失,之后将整体分液,用二氯甲烷萃取有机相,无水MgSO4干燥,减压旋蒸之后重结晶得到2-溴芴;
步骤2:将2-溴芴与二甲基亚砜和氢氧化钾粉末放入瓶中,加热并搅拌至全部溶解,再用恒压滴液漏斗缓慢滴加碘甲烷与二甲基亚砜,反应24小时,待温度降温到室温后倒入水中,析出固体、过滤烘干后加入无水乙醇中回流,冷却之后得到9,9-二甲基-2-溴芴;
步骤3:将9,9-二甲基-2-溴芴、联硼酸频哪醇酯、二氯化钯及醋酸钾混合加入到瓶中,再向其中加入DMF,用氮气反复脱气后在氮气保护下100℃反应24小时,冷却至室温,用二氯甲烷萃取有机相,用无水硫酸钠干燥,最后用石油醚/二氯甲烷混合溶剂进行柱层析分离,得到9,9-二甲基芴-2-硼酸频哪醇酯;
步骤4:将二氧六环与碳酸钾溶液混合后进行反复脱气并用氮气净化,再依次加入3,5-二溴代芳烃衍生物、9,9-二甲基芴-2-硼酸频哪醇酯、四三苯基膦钯,在80~100℃并在氮气保护下回流16小时,用二氯甲烷萃取有机相,再用水和饱和食盐水清洗,用无水硫酸镁干燥,减压旋蒸后用石油醚与乙酸乙酯混合溶剂进行柱层析分离,得到化合物,所述3,5-二溴代芳烃衍生物的结构式为,所述R= -CHO、-COOH、-Br、-I、-NO2、-NH2、-OCH3、-CH3、-CN、-NHCOCH3、-CF3或-CCl3。
上述的具有AIE特性的芴类衍生物作为识别小分子物质荧光探针的应用,尤其是作为识别色氨酸荧光探针的应用。
本发明所制备的芴类衍生物具有聚集诱导发光(AIE)特性,可作为荧光探针应用于识别生物小分子,不仅对色氨酸有高效专一性识别(检测限为1.15μM),而且还可以用于检测炸药、阴离子、金属阳离子(包括稀土金属)等小分子物质。
附图说明
图1是本发明实施例所制备的化合物的1H NMR谱图。
图2是本发明实施例所制备的化合物在THF/H2O混合物中的荧光光谱和荧光变化趋势图。
图3是本发明实施例所制备的化合物在THF/无水乙醇混合物中的荧光光谱和荧光变化趋势图。
图4是本发明实施例所制备的化合物作为荧光探针与不同氨基酸相互作用的荧光光谱图。
图5为本发明实施例所制备的化合物作为荧光探针与不同浓度梯度的色氨酸相互作用的UV图。
图6为本发明实施例所制备的化合物作为荧光探针对氨基酸的竞争性实验荧光光谱图。
具体实施方式
实施例:
本发明的具有AIE特性的芴类衍生物,制备方法依次按照如下步骤进行:
步骤1:先将5.0g芴与150 mL氯仿加入到瓶中,然后向瓶中加入75mg无水三氯化铁,冰水浴搅拌冷却至0℃后再向瓶中滴加1.6 mL液溴,移去冰水浴继续搅拌3小时,再向反应体系滴加100 mL饱和的硫代硫酸钠溶液至红色完全消失,之后将整体分液,用二氯甲烷萃取有机相3-4次,无水MgSO4干燥,在减压旋蒸之后,得到黄色固体,将固体溶解于80 mL无水乙醇中,冷却析出晶体,即得到2-溴芴;
步骤2:将7.5 g 2-溴芴与30 mL二甲基亚砜和5.0 g氢氧化钾粉末放入瓶中,加热并搅拌至全部溶解,再将6.3 g碘甲烷与30 mL二甲基亚砜加入到恒压滴液漏斗中,用恒压滴液漏斗缓慢滴加碘甲烷与二甲基亚砜,反应24小时停止反应,待温度降温到室温后倒入150 mL水中,析出固体、过滤烘干后加入80 mL无水乙醇中回流,冷却之后得到9,9-二甲基-2-溴芴;
步骤3:将5.0 g 9,9-二甲基-2-溴芴、4.8 g联硼酸频哪醇酯、0.2 g二氯化钯(dppf)及4.0 g醋酸钾混合加入到瓶中,再向其中加入80 mL DMF,用氮气反复脱气后在氮气保护下100℃反应24小时,冷却至室温,用二氯甲烷萃取有机相3-4次,用无水硫酸钠干燥,最后用石油醚/二氯甲烷(5/1,v/ v)混合溶剂进行柱层析分离,得到9,9-二甲基芴-2-硼酸频哪醇酯;
步骤4:将60 mL二氧六环与20 ml碳酸钾(2 mol/L)溶液混合后进行反复脱气并用氮气净化,再依次加入1.5 g 3,5-二溴苯甲醛、3.64 g 9,9-二甲基芴-2-硼酸频哪醇酯、0.2 g四三苯基膦钯,在85℃并在氮气保护下回流16小时,用二氯甲烷萃取有机相3-4次,再用水和饱和食盐水清洗3-4次后,用无水硫酸镁干燥,减压旋蒸之后,用石油醚与乙酸乙酯(20/1,v/v)混合溶剂进行柱层析分离,得到化合物。
所制备化合物的1H NMR谱图如图1所示,结构式如下:
实验:
实验1:实施例所制备的化合物(以下简称化合物)的AIE性能实验
将化合物溶解于THF溶液中,按照H2O体积分数从0%-90%配制成不同浓度的THF-H2O溶液,收集它们的发射光谱,其荧光光谱(A)和荧光变化趋势图(B)如图2所示。从图2可以看出,化合物在稀溶液中几乎不发光,当加入水时荧光强度明显增强,当含水量达到70%时,不溶性颗粒被分离出来,荧光强度达到最大值,比原始值高8.14倍。将化合物溶解于THF溶液中,按照乙醇体积分数从0%-90%配制了不同浓度的THF-无水乙醇溶液,收集它们的发射光谱,其荧光光谱(A)和荧光变化趋势图(B)如图3所示。从图3可以看出,化合物在无水乙醇中也不溶解,随着无水乙醇的增多,溶液从无荧光变成了浅绿色的荧光,当无水乙醇达到90%时,荧光强度比原始值高679.9倍。图3中有两段发射波长,第一段发射波长由375.2nm蓝移到352.2nm,第二段波长由449.8nm红移到467.4nm。
实验2:化合物作为荧光探针与不同氨基酸相互作用实验
通过紫外光谱测试结果将化合物的最大吸收波长(λmax=300nm)作为荧光光谱测试的激发波长,使用DMF作为配置化合物的荧光分析溶液,分别在其中加入色氨酸(Trp)、白氨酸(Leu),丝氨酸(Ser)、甲硫氨基酸(Met),丙氨酸(Ala),异亮氨酸(Ile)、苏氨酸(Thr)、脯氨酸(Pro)、精氨酸(Arg)、赖氨酸(Lys)、天冬氨酸(Asp)、谷氨酸(Glu)、酪氨酸(Tyr)、苯丙氨酸(Phe)、缬氨酸(Val)、半胱氨酸(Cys),组氨酸(His)、甘氨酸(Gly),进行荧光发射光谱测定,荧光光谱图如图4所示。结果表明:只有在加入了色氨酸时,荧光强度才显著增强,而相同条件下加入其它氨基酸时,没有观察到显著的荧光响应。
实验3:化合物作为荧光探针与不同浓度梯度的色氨酸相互作用实验
在化合物中加入不同浓度(0,10,20,……100μM)色氨酸(Trp)进行了吸收滴定实验,其UV图如图5所示。
结果表明随着Trp的逐渐加入,294nm处吸收强度增强,同时裂分成了两个峰,说明化合物对Trp具有选择性,检测限为1.15μM。
实施例4:化合物作为荧光探针对氨基酸的竞争性实验
为了确定化合物是否对色氨酸进行特异选择性识别,分别研究了白氨酸(Leu),丝氨酸(Ser)、甲硫氨基酸(Met),丙氨酸(Ala),异亮氨酸(Ile)、苏氨酸(Thr)、脯氨酸(Pro)、精氨酸(Arg)、赖氨酸(Lys)、天冬氨酸(Asp)、谷氨酸(Glu)、酪氨酸(Tyr)、苯丙氨酸(Phe)、缬氨酸(Val)、半胱氨酸(Cys),组氨酸(His)、甘氨酸(Gly)以及色氨酸(Trp)与上述氨基酸共同存在下的荧光光谱,如图6所示。
结果表明:在Trp的存在下,混合物的发射强度增强,而在没有Trp、只有其它氨基酸的情况下发射峰强度几乎没有改变。说明即使在其他氨基酸的存在下,化合物的荧光强度也在Trp的加入下显著提高,说明对Trp有很高的选择性,可以高效、专一的检测色氨酸。其原理是当荧光探针中加入Trp后,具有电子给予能力的Trp与荧光探针结合后,降低了Trp的给电子能力,抑制了PET过程,荧光基团中被光激发的电子可以直接跃迁回到原基态轨道,从而增强了荧光基团的荧光发射。
Claims (3)
2.一种如权利要求1所述的具有AIE特性的芴类衍生物的制备方法,其特征在于依次按照如下步骤进行:
步骤1:先将芴与氯仿加入到瓶中,然后向瓶中加入无水三氯化铁,冰水浴搅拌冷却至0℃后再向瓶中滴加液溴,移去冰水浴继续搅拌2.5~3.5小时,再向反应体系滴加饱和的硫代硫酸钠溶液至红色完全消失,之后将整体分液,用二氯甲烷萃取有机相,无水MgSO4干燥,减压旋蒸之后重结晶,得到2-溴芴;
步骤2:将2-溴芴与二甲基亚砜和氢氧化钾粉末放入瓶中,加热并搅拌至全部溶解,再用恒压滴液漏斗缓慢滴加碘甲烷与二甲基亚砜,反应24小时,待温度降温到室温后倒入水中,析出固体、过滤烘干后加入无水乙醇中回流,冷却之后得到9,9-二甲基-2-溴芴;
步骤3:将9,9-二甲基-2-溴芴、联硼酸频哪醇酯、二氯化钯及醋酸钾混合加入到瓶中,再向其中加入DMF,用氮气反复脱气后在氮气保护下100℃反应24小时,冷却至室温,用二氯甲烷萃取有机相,用无水硫酸钠干燥,最后用石油醚/二氯甲烷混合溶剂进行柱层析分离,得到9,9-二甲基芴-2-硼酸频哪醇酯;
3.一种如权利要求1所述的具有AIE特性的芴类衍生物作为识别小分子物质荧光探针的应用,其特征在于:作为识别色氨酸荧光探针的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110381081.4A CN113336622B (zh) | 2021-04-09 | 2021-04-09 | 具有aie特性的芴类衍生物、制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110381081.4A CN113336622B (zh) | 2021-04-09 | 2021-04-09 | 具有aie特性的芴类衍生物、制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113336622A CN113336622A (zh) | 2021-09-03 |
CN113336622B true CN113336622B (zh) | 2022-06-10 |
Family
ID=77467977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110381081.4A Expired - Fee Related CN113336622B (zh) | 2021-04-09 | 2021-04-09 | 具有aie特性的芴类衍生物、制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113336622B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114853656B (zh) * | 2022-05-12 | 2023-07-11 | 辽宁师范大学 | 具有aee特性的咔唑类衍生物、制备方法及应用 |
CN115594629A (zh) * | 2022-09-20 | 2023-01-13 | 辽宁师范大学(Cn) | 具有aee特性的咔唑类衍生物及其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102307238B1 (ko) * | 2014-12-26 | 2021-10-01 | 솔루스첨단소재 주식회사 | 유기 화합물 및 이를 포함하는 유기 전계 발광 소자 |
KR102639370B1 (ko) * | 2016-01-27 | 2024-02-22 | 에스에프씨 주식회사 | 신규한 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자 |
CN110845501B (zh) * | 2018-12-10 | 2021-03-19 | 广州华睿光电材料有限公司 | 一种芳胺化合物及其在有机电子器件上的应用 |
-
2021
- 2021-04-09 CN CN202110381081.4A patent/CN113336622B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN113336622A (zh) | 2021-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | A low dose, highly selective and sensitive colorimetric and fluorescent probe for biothiols and its application in bioimaging | |
Chen et al. | A novel imidazo [1, 5-α] pyridine-based fluorescent probe with a large Stokes shift for imaging hydrogen sulfide | |
CN113336622B (zh) | 具有aie特性的芴类衍生物、制备方法及应用 | |
Wang et al. | A fluorescent sensor bearing nitroolefin moiety for the detection of thiols and its biological imaging | |
Yue et al. | A Bodipy-based derivative for selective fluorescence sensing of homocysteine and cysteine | |
Xu et al. | Label-free fluorescence detection of mercury (II) and glutathione based on Hg2+-DNA complexes stimulating aggregation-induced emission of a tetraphenylethene derivative | |
Zhang et al. | A simple and readily available fluorescent turn-on probe for cysteine detection and bioimaging in living cells | |
CN106432315B (zh) | 一种基于氟硼吡咯的Cys荧光探针的制备方法和应用 | |
Fan et al. | A simple fluorescent probe for sensing cysteine over homocysteine and glutathione based on PET | |
Shen et al. | A specific AIE and ESIPT fluorescent probe for peroxynitrite detection and imaging in living cells | |
Qu et al. | A fluorescence “switch-on” approach to detect hydrazine in aqueous solution at neutral pH | |
Fu et al. | Rational design of an “on-off-on” fluorescent assay for chiral amino acids based on quantum dots and nanoporphyrin | |
Liu et al. | Fluorescence turn-on detection of cysteine over homocysteine and glutathione based on “ESIPT” and “AIE” | |
Wang et al. | Two-isophorone fluorophore-based design of a ratiometric fluorescent probe and its application in the sensing of biothiols | |
CN108358906A (zh) | 一种特异性区分不同硫醇的荧光探针 | |
Huang et al. | A novel anthracene-based receptor: highly sensitive fluorescent and colorimetric receptor for fluoride | |
Hou et al. | The first ratiometric probe for lysine in water | |
CN111253935A (zh) | 一种双通道检测极性和粘度的双光子荧光探针及其制备方法和用途 | |
Wang et al. | Spectrophotometric determination of cysteine with gold nanoparticles stabilized with single-stranded oligonucleotides | |
Ni et al. | Dual-state emission difluoroboron derivatives for selective detection of picric acid and reversible acid/base fluorescence switching | |
WO2001063265A1 (fr) | Procede de mesure dans lequel on utilise la fluorescence de longue duree du type d'excitation | |
CN104956206A (zh) | 经由发光猝灭检测分析物的方法 | |
Katla et al. | Styrylisoxazole-based fluorescent probes for the detection of hydrogen sulfide | |
Kim et al. | An imidazole-appended p-phenylene-Cu (II) ensemble as a chemoprobe for histidine in biological samples | |
KarakuŞ | An anthracene based fluorescent probe for the selective and sensitive detection of Chromium (III) ions in an aqueous medium and its practical application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220610 |
|
CF01 | Termination of patent right due to non-payment of annual fee |